Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × INDUSTRY × Hematuria × Clear all

Status

Unknown 2 Terminated 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 69 Breast Neoplasms 45 Colorectal Neoplasms 40 Neoplasms 34 Multiple Myeloma 27 Advanced Solid Tumors 25 Lung Neoplasms 24 Carcinoma, Hepatocellular 24 Prostatic Neoplasms 23 Ovarian Neoplasms 22 Small Cell Lung Carcinoma 21 Recurrence 21 Pancreatic Neoplasms 21 Neoplasm Metastasis 19 Advanced Solid Tumor 19 Glioblastoma 18 Leukemia, Myeloid, Acute 16 Endometrial Neoplasms 15 Stomach Neoplasms 13 Melanoma 13 Glioma 13 Lymphoma, Follicular 11 Uterine Cervical Neoplasms 10 Triple Negative Breast Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Lymphoma 10 Head and Neck Neoplasms 10 Urinary Bladder Neoplasms 9 Sarcoma 9 Non-Muscle Invasive Bladder Neoplasms 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06912672 2025-04-08

UMT-UC

Shanghai Epiprobe Biotechnology Co., Ltd.

Not yet recruiting

Carcinoma, Transitional Cell, Hematuria

Data powered by HemOnc (CC BY 4.0) Colophon ⚡